21187-98-4
21187-98-4
Chemical Structure
Gliclazide
Synonym(s): S1702; SE1702
- CAS No.: 21187-98-4
- Formula:C15H21N3O3S
- Molecular Weight:323.41
IUPAC Name: N-((hexahydrocyclopenta[c]pyrrol-2(1H)-yl)carbamoyl)-4-methylbenzenesulfonamide
InChIKey: BOVGTQGAOIONJV-UHFFFAOYSA-N
SMILES: O=S(C1=CC=C(C)C=C1)(NC(NN2CC3C(CCC3)C2)=O)=O
Biological Activity: Gliclazide (S1702) is a whole-cell beta-cell ATP-sensitive potassium currents blocker with an IC50 of 184 nM. Gliclazide is used as an antidiabetic[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Gliclazide | 99.58% | Gliclazide (S1702) is a whole-cell beta-cell ATP-sensitive potassium currents blocker with an IC50 of 184 nM. Gliclazide is used as an antidiabetic. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Gliclazide (Standard) | 99.95% | Gliclazide (Standard) is the analytical standard of Gliclazide. This product is intended for research and analytical applications. Gliclazide (S1702) is a whole-cell beta-cell ATP-sensitive potassium currents blocker with an IC50 of 184 nM. Gliclazide is used as an antidiabetic. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Gliclazide-d4 | Gliclazide-d4 (S1702 D4) is the deuterium labeled Gliclazide. Gliclazide (S1702) is a whole-cell beta-cell ATP-sensitive potassium currents blocker with an IC50 of 184 nM. Gliclazide is used as an antidiabetic. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
